176 related articles for article (PubMed ID: 18368750)
1. [Acellular pertussis vaccine].
Zakharova NS; Britsina MV; Mertsalova NU; Bazhanova IG; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Semenov BF
Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):35-41. PubMed ID: 18368750
[TBL] [Abstract][Full Text] [Related]
2. [Humoral response to the injection of acellular Pertussis vaccine].
Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
[TBL] [Abstract][Full Text] [Related]
3. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
4. [New acellular pertussis vaccine, containing glucosaminylmuramyldipeptide].
Semenov BF; Zakharova NS; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Valiakina TI; Komaleva RL; Andronova TM; Nesmeianov VA
Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):31-6. PubMed ID: 15636136
[TBL] [Abstract][Full Text] [Related]
5. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine].
Zaĭtsev EM; Poddubikov AV; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Bazhanova IG; Plekhanova NG
Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):20-4. PubMed ID: 24738289
[TBL] [Abstract][Full Text] [Related]
6. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
7. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
8. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of pertussis: development and use of acellular pertussis vaccine].
Chuprinina RP; Alekseeva IA; Ozeretskovskiĭ NA
Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):99-105. PubMed ID: 16532655
[TBL] [Abstract][Full Text] [Related]
10. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
12. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.
Dalby T; Sørensen C; Petersen JW; Krogfelt KA
APMIS; 2010 Dec; 118(12):968-72. PubMed ID: 21091778
[TBL] [Abstract][Full Text] [Related]
13. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.
Meade BD; Lynn F; Reed GF; Mink CM; Romani TA; Deforest A; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):595-600. PubMed ID: 7659484
[TBL] [Abstract][Full Text] [Related]
14. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.
von König CH; Herden P; Palitzsch D; Schneeweiss B; Bier N
Pediatr Infect Dis J; 2000 Aug; 19(8):757-9. PubMed ID: 10959748
[No Abstract] [Full Text] [Related]
16. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
[TBL] [Abstract][Full Text] [Related]
17. [Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases].
Kostinov MP; Tarasova AA; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):61-4. PubMed ID: 18277540
[TBL] [Abstract][Full Text] [Related]
18. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
[TBL] [Abstract][Full Text] [Related]
19. Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.
Giammanco A; Taormina S; Chiarini A; Dardanoni G; Stefanelli P; Salmaso S; Mastrantonio P
Vaccine; 2003 May; 21(17-18):1924-31. PubMed ID: 12706678
[TBL] [Abstract][Full Text] [Related]
20. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
